
Overview
Dr. Katherine Antel earned her medical degree from the University of Cape Town, South Africa and where she went on to complete an internal medicine residency and a fellowship in hematology and bone marrow transplant. Dr. Antel went on to pursue 3-year research fellowship in lymphoid genomics at the Dana-Farber Cancer Institute, Boston U.S. Her research area of interest is in lymphoid biology, and lymphoid genomics. Dr. Antel is an associate professor at the Medical University of South Carolina in Charleston. Her clinical and research areas of interest include the biology and genomics of aggressive lymphoma and the development of clinical assays to detect and diagnose lymphoma using cell-free DNA.
Dr. Antel is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Lymphofollicular Hyperplasia, Lymphadenitis, Hodgkin Lymphoma, and Burkitt Lymphoma.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles. Dr. Antel is currently accepting new patients.
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
86 Jonathan Lucas St, 86 Jonathan Lucas St, Charleston, SC 29425
Additional Areas of Focus
Dr. Antel has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MUSC University Hospital
Robert Stuart is a Hematologist and an Oncologist practicing medicine in Charleston, South Carolina. Dr. Stuart is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
MUSC Health Hematology Oncology At Hollings Cancer Center
Dr. Thai Ho has been caring for patients affected by genitourinary cancers for over 10 years. His area of expertise and the focus of his research is in treating kidney and bladder cancers. He also sees patients with kidney, bladder, upper tract urothelial, and prostate cancers, as well as patients affected by hereditary cancer syndromes. Dr. Ho completed the Baylor College of Medicine Physician Scientist Program in 2006, internal medicine residency at Washington University in St. Louis in 2009, and Medical Oncology Fellowship at MD Anderson Cancer Center in 2012.Dr. Ho's research is funded by the National Institutes of Health and Department of Defense to better match cancer patients with targeted therapies by using precision medicine approaches to identify a cancer's unique vulnerabilities. At MUSC Hollings Cancer Center, Dr. Ho is the Director of Precision Medicine and an Associate Professor in the Division of Hematology \& Oncology. Prior to joining MUSC, Dr. Ho was an Associate Professor faculty the Mayo Clinic where he was a member of the Center for Individualized Medicine Epigenomics Group, Genomic Tumor Board, and von Hippel-Lindau Clinic. Dr. Ho is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Orchiectomy. Dr. Ho is currently accepting new patients.
MUSC Health Cardiology At West Ashley Medical Pavilion
Dr. Daniel Judge is a professor of medicine in cardiology at MUSC. He received his medical degree at the University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology, and advanced heart failure/transplant cardiology at Johns Hopkins. He is board-certified in both cardiology and advanced heart failure/transplant cardiology.Dr. Judge takes care of adult patients with inherited forms of cardiovascular disease, as well as congestive heart failure. As director of the cardiovascular genetics program, Dr. Judge has extensive experience caring for individuals and families with inherited forms of cardiomyopathy, aortic aneurysm, amyloidosis, and cardiac involvement from other genetic conditions.He has authored more than 150 scientific manuscripts. Dr. Judge is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Transthyretin Amyloid Cardiomyopathy, Cardiac Amyloidosis, Heart Transplant, and Cardiac Ablation. Dr. Judge is currently accepting new patients.
Frequently Asked Questions about Dr. Katherine R. Antel
How do I make an appointment with Dr. Katherine R. Antel?
You can book an appointment with Dr. Katherine R. Antel by calling their office at 843-792-9300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Katherine R. Antel a top-rated expert for Lymphofollicular Hyperplasia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Katherine R. Antel is classified as an Distinguished expert for Lymphofollicular Hyperplasia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Katherine R. Antel specialize in?
While Dr. Katherine R. Antel is a Hematology Oncology, they have specific expertise in Lymphofollicular Hyperplasia, Lymphadenitis, and Hodgkin Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Katherine R. Antel participate in research or clinical trials?
Yes. Dr. Katherine R. Antel has published 21 articles and abstracts on conditions like Lymphofollicular Hyperplasia. You can view a list of Dr. Katherine R. Antel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Katherine R. Antel accept my insurance?
Dr. Katherine R. Antel accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 843-792-9300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lymphofollicular HyperplasiaDr. Antel isDistinguished. Learn about Lymphofollicular Hyperplasia.
- Advanced
- LymphadenitisDr. Antel isAdvanced. Learn about Lymphadenitis.
- Experienced
- B-Cell LymphomaDr. Antel isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaDr. Antel isExperienced. Learn about Burkitt Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Antel isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Hodgkin LymphomaDr. Antel isExperienced. Learn about Hodgkin Lymphoma.
- Non-Hodgkin LymphomaDr. Antel isExperienced. Learn about Non-Hodgkin Lymphoma.

